09:43 AM EST - Microbix Biosystems Inc. : And Aurevia Oy via its Labquality EQAS affiliate (Aurevia), announce a pilot external quality assessment program to help clinical laboratories establish their proficiency at using molecular diagnostic methods (e.g., PCR tests) to diagnose bacterial vaginosis. Microbix Biosystems Inc.
shares T.MBX are trading unchanged at $0.37.
